COLDSTREAM CAPITAL MANAGEMENT INC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1082339 BELLEVUE, WA

Position in ALNY

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$447,005

-$178,896 QoQ

Shares Held

1,351

-14.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 64.91487786824575.ToString("F0")% Shared 0.ToString("F0")% None 35.085122131754254.ToString("F0")%

Healthcare · as of Mar 31, 2026

COLDSTREAM CAPITAL MANAGEMENT INC holds $11,059,687 across 19 Biotechnology names. ALNY ranks #8 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,537	$2,919,031
2	REGN	Regeneron Pharmaceuticals, Inc.	1,874	$1,447,927
3	JAZZ	Jazz Pharmaceuticals plc	3,404	$643,526
4	INSM	INSMED Inc	3,737	$611,074
5	HALO	Halozyme Therapeutics, Inc.	8,863	$572,815
6	OMER	Omeros Corp	54,130	$571,612
7	MRNA	Moderna, Inc.	8,859	$450,037
8	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,351	$447,005

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$447,005	1,351	-14.2%	Shares	Sole	2026-05-08
2025-12-31	$625,901	1,574	-4.0%	Shares	Sole	2026-02-09
2025-09-30	$747,840	1,640	+2.4%	Shares	Sole	2025-11-19
2025-06-30	$522,396	1,602	+48.5%	Shares	Sole	2025-08-12
2025-03-31	$291,351	1,079	-3.1%	Shares	Sole	2025-05-13
2024-12-31	$261,900	1,113	-8.1%	Shares	Sole	2025-02-14
2024-09-30	$333,061	1,211	+43.7%	Shares	Sole	2024-11-18
2024-06-30	$204,849	843	—	Shares	Sole	2024-08-07
No filing history on record for this holder in this stock.